T78.1
Conditions
Interventions
Group 1: Children and adults with allergy to peanut and/or hazelnut will be enrolled in this study. Blood will be taken for allergy diagnostic (total and specific IgE) as well as for the basophil acti
Sponsors
Charité Campus Charité Mitte
Eligibility
Sex/Gender
All
Age
1 Years to 70 Years
Inclusion criteria
Inclusion criteria: children (>=1 year) and adults (>= 18 yerars), both sex; Known food allergy to peanut and/or hazelnut; Signed informed consent of patient/parents
Exclusion criteria
Exclusion criteria: Skin disease in the test areal of the skin prick test; Increased risk of sever allergic reactions, e.g. therapy with beta-blocker and/or ACE-inhibitors; Usage of antihistamines 3-5 days before skin prick test or oral food challenge; Systemic immunosuppression; Uncontrolled asthma; Pregnancy or lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean wheal diameter in the skin prick test with differently processed nuts | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean wheal diameter in the skin prick test with differently processed nuts compared between children and adults Basophil actication test with differently processed nuts compared between children and adults | — |
Countries
Germany
Contacts
Public ContactSabine Dölle-Bierke
Charité-Universitätsmedizin BerlinKlinik für Dermatologie, Venerologie und Allergologie
Outcome results
None listed